Sign in
4

Changes in Ownership

Evofem Biosciences, Inc. Filed Acc 0001209191-15-053913

VP, Pharma Dev & Manufacturing acquired 10,848 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Kemmerer Christopher VP, Pharma Dev & Manufacturing 2015-06-12 Option exercise +10,848 $1.22 $13,235 10,848 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Kemmerer Christopher VP, Pharma Dev & Manufacturing 2015-06-12 Option exercise · Common Stock (Right to Buy) −10,848 0 D: show line 2 in the form
Loading xslF345X03/doc4.xml…